Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Urinary bladder cancer risk factors in an area of former coal, iron, and steel industries in Germany.

Krech E, Selinski S, Blaszkewicz M, Bürger H, Kadhum T, Hengstler JG, Truss MC, Golka K.

J Toxicol Environ Health A. 2017;80(7-8):430-438. doi: 10.1080/10937404.2017.1304719. Epub 2017 Jul 11.

PMID:
28696895
2.

Polymorphic enzymes, urinary bladder cancer risk, and structural change in the local industry.

Ovsiannikov D, Selinski S, Lehmann ML, Blaszkewicz M, Moormann O, Haenel MW, Hengstler JG, Golka K.

J Toxicol Environ Health A. 2012;75(8-10):557-65. doi: 10.1080/15287394.2012.675308.

PMID:
22686316
3.

Occupational bladder cancer: Polymorphisms of xenobiotic metabolizing enzymes, exposures, and prognosis.

Lukas C, Selinski S, Prager HM, Blaszkewicz M, Hengstler JG, Golka K.

J Toxicol Environ Health A. 2017;80(7-8):439-452. doi: 10.1080/10937404.2017.1304731. Epub 2017 Jul 11.

PMID:
28696839
4.

Occupational risk factors for prostate cancer in an area of former coal, iron, and steel industries in Germany. Part 2: results from a study performed in the 1990s.

Krech S, Selinski S, Bürger H, Hengstler JG, Jedrusik P, Hodzic J, Knopf HJ, Golka K.

J Toxicol Environ Health A. 2016;79(22-23):1130-1135.

PMID:
27924709
5.

Occupational risk factors for prostate cancer in an area of former coal, iron, and steel industries in Germany. Part 1: Results from a study performed in the 1980s.

Dickhut S, Urfer W, Reich S, Bandel T, Bremicker KD, Neugebauer W, Sökeland J, Bolt HM, Golka K.

J Toxicol Environ Health A. 2016;79(22-23):1125-1129.

PMID:
27924710
6.

Urothelial cancer of the bladder in an area of former coal, iron, and steel industries in Germany: a case-control study.

Golka K, Bandel T, Schlaefke S, Reich SE, Reckwitz T, Urfer W, Bremicker KD, Neugebauer W, Soekeland J, Bolt HM.

Int J Occup Environ Health. 1998 Apr-Jun;4(2):79-84.

PMID:
10026468
7.

N-Acetyltransferase 2 and glutathione s-transferase M1 in colon and rectal cancer cases from an industrialized area.

Golka K, Roemer HC, Weistenhöfer W, Blaszkewicz M, Hammad S, Reckwitz T, Loehlein D, Hartel M, Hengstler JG, Geller F.

J Toxicol Environ Health A. 2012;75(8-10):572-81. doi: 10.1080/15287394.2012.675310.

PMID:
22686318
8.

Miners compensated for pneumoconiosis and glutathione s-transferases M1 and T1 genotypes.

Zimmermann A, Ebbinghaus R, Prager HM, Blaszkewicz M, Hengstler JG, Golka K.

J Toxicol Environ Health A. 2012;75(8-10):582-7. doi: 10.1080/15287394.2012.675311.

PMID:
22686319
9.

N-Acetyltransferase 2 (NAT2) and Glutathione S-Transferase µ (GSTM1) in Bladder-cancer Patients in a Highly Industrialized Area.

Golka K, Reckwitz T, Kempkes M, Cascorbi I I, Blaskewicz M, Reich SE, Roots I I, Soekeland J, Schulze H, Bolt HM.

Int J Occup Environ Health. 1997 Apr;3(2):105-110.

PMID:
9891107
10.

Polymorphisms of xenobiotic metabolizing enzymes in bladder cancer patients of the Semmelweis University Budapest, Hungary.

Ebbinghaus D, Bánfi G, Selinski S, Blaszkewicz M, Bürger H, Hengstler JG, Nyirády P, Golka K.

J Toxicol Environ Health A. 2017;80(7-8):423-429. doi: 10.1080/10937404.2017.1304736. Epub 2017 Jul 11.

PMID:
28696897
11.

[Occupational and non-occupational risk factors in bladder cancer patients in an industrialized area located in former East-Germany].

Golka K, Seidel T, Dietrich H, Roth G, Rötzel C, Thier R, Geller F, Reckwitz T, Schulze H.

Aktuelle Urol. 2005 Sep;36(5):417-22. German.

PMID:
16163604
12.

Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.

Song DK, Xing DL, Zhang LR, Li ZX, Liu J, Qiao BP.

Cancer Detect Prev. 2009;32(5-6):416-23. doi: 10.1016/j.cdp.2009.02.003. Epub 2009 Mar 20.

PMID:
19303722
13.

Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.

Okkels H, Sigsgaard T, Wolf H, Autrup H.

Cancer Epidemiol Biomarkers Prev. 1997 Apr;6(4):225-31.

14.

NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

García-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Castaño-Vinyals G, Yeager M, Welch R, Chanock S, Chatterjee N, Wacholder S, Samanic C, Torà M, Fernández F, Real FX, Rothman N.

Lancet. 2005 Aug 20-26;366(9486):649-59.

15.

GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.

Moore LE, Baris DR, Figueroa JD, Garcia-Closas M, Karagas MR, Schwenn MR, Johnson AT, Lubin JH, Hein DW, Dagnall CL, Colt JS, Kida M, Jones MA, Schned AR, Cherala SS, Chanock SJ, Cantor KP, Silverman DT, Rothman N.

Carcinogenesis. 2011 Feb;32(2):182-9. doi: 10.1093/carcin/bgq223. Epub 2010 Oct 29.

16.
17.

GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.

Hung RJ, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, Donato F, Gelatti U, Spaliviero M, Placidi D, Carta A, Scotto di Carlo A, Porru S.

Int J Cancer. 2004 Jul 1;110(4):598-604.

18.

Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population.

Rouissi K, Ouerhani S, Marrakchi R, Ben Slama MR, Sfaxi M, Ayed M, Chebil M, El Gaaied AB.

Cancer Genet Cytogenet. 2009 Apr 15;190(2):101-7. doi: 10.1016/j.cancergencyto.2009.01.007.

PMID:
19380028
19.

Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.

Salagovic J, Kalina I, Stubna J, Habalová V, Hrivnák M, Valanský L, Kohút A, Biros E.

Neoplasma. 1998;45(5):312-7.

PMID:
9921921
20.

Gender-specific effects of NAT2 and GSTM1 in bladder cancer.

Schnakenberg E, Lustig M, Breuer R, Werdin R, Hübotter R, Dreikorn K, Schloot W.

Clin Genet. 2000 Apr;57(4):270-7.

PMID:
10845567

Supplemental Content

Support Center